Stay updated on Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial

Sign up to get notified when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.4%
    Check dated 2025-05-01T06:00:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-23T22:39:17.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding midostaurin's efficacy in treating Acute Myeloid Leukemia (AML) and the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    14%
    Check dated 2025-04-16T14:50:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.2%
    Check dated 2025-04-09T10:27:16.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:38:48.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T14:11:22.000Z thumbnail image

Stay in the know with updates to Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.